Prime Minister Narendra Modi has played a pivotal role in creating a generic medicines revolution
Share
Prime Minister Narendra Modi has played a pivotal role in creating a generic medicines revolution in India through several policy initiatives and government programs aimed at making affordable healthcare accessible to the masses. Here are the key ways in which Modi's government has driven this revolution:
1. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
- Launched in 2015, this flagship initiative promotes the availability of affordable generic medicines across India through Janaushadhi Kendras (government-run outlets). These stores sell unbranded generic medicines that are 50-90% cheaper than their branded counterparts.
- By 2023, there were over 9,000 Janaushadhi Kendras across India, significantly improving access to affordable medicines, especially in rural and semi-urban areas.
2. Affordable Healthcare Push
- Modi’s government has emphasized affordable healthcare as a cornerstone of its policies, with a particular focus on reducing out-of-pocket medical expenses for the common man. Generic medicines are a key part of this strategy as they offer the same therapeutic effects as branded drugs at a fraction of the cost.
- The government has promoted the prescription and use of generic medicines through various public health campaigns, encouraging doctors to prescribe generics instead of expensive branded medicines.
3. Regulatory Reforms
- The government has taken steps to streamline the approval process for generic drugs, which has allowed more manufacturers to produce and distribute affordable generics.
- The National Pharmaceutical Pricing Authority (NPPA) has been empowered to regulate and cap the prices of essential medicines, including generics. This has ensured that life-saving drugs are available at controlled, affordable prices.
4. Increased Public Awareness
- Modi’s government has driven a public awareness campaign to educate people about the benefits and efficacy of generic medicines, combating the common misconception that generics are inferior to branded medicines.
- This awareness has led to a growing demand for generics across India, further reducing the dependency on expensive branded drugs.
5. Ayushman Bharat (PM-JAY)
- The Ayushman Bharat scheme, launched in 2018, is the world's largest government-funded healthcare program, providing health insurance coverage to over 500 million people. Generic medicines play a key role in the success of this initiative, helping the government keep treatment costs low.
- The focus on generic medicines within this program ensures that poor and vulnerable populations have access to essential treatments without financial hardship.
6. Support for Indian Pharmaceutical Industry
- Modi's government has supported the domestic pharmaceutical industry, which is one of the largest producers of generic medicines globally. This includes:
- Incentives for manufacturing generic drugs.
- Encouraging exports of Indian generics to international markets, boosting the "Make in India" campaign.
- Collaborating with state governments to promote the setting up of pharmaceutical parks and generic drug manufacturing units.
7. Prescription of Generics in Government Hospitals
- Government hospitals and public health centers under the Modi government are increasingly prescribing generic medicines as part of standard treatment protocols. This move ensures that even the poorest sections of society can access affordable medications.
Impact:
- The result of these efforts has been a significant increase in the availability, affordability, and usage of generic medicines across India, helping millions of people access quality healthcare without incurring high costs.
- The generic medicines revolution under Modi has been lauded for its ability to lower healthcare costs, making India a global hub for the production and distribution of affordable generic drugs.
In summary, through policy reforms, awareness campaigns, and government initiatives like the Janaushadhi Yojanaand Ayushman Bharat, Modi has driven a revolution in generic medicines that is transforming healthcare in India, making it more accessible and affordable.